These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Methodology of controlled clinical studies on the primary treatment of operable breast cancer]. Scheurlen H; Olschewski M; Leibbrand D Strahlentherapie; 1984 Aug; 160(8):459-68. PubMed ID: 6474519 [TBL] [Abstract][Full Text] [Related]
5. Clinical considerations in the design of clinical trials. Carter SK Cancer Treat Rep; 1980; 64(2-3):367-71. PubMed ID: 7407773 [TBL] [Abstract][Full Text] [Related]
6. [Can one be a urologist without being familiar with the methodology of therapeutic trials?]. Bergmann JF Prog Urol; 1996 Apr; 6(2):199-204. PubMed ID: 8777412 [TBL] [Abstract][Full Text] [Related]
7. Sequential clinical trials in cancer research. George SL Cancer Treat Rep; 1980; 64(2-3):393-7. PubMed ID: 7407775 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of clinical trials. Randomized v historical controls. Sacks HS; Chalmers TC; Smith H Arch Intern Med; 1983 Apr; 143(4):753-5. PubMed ID: 6838297 [TBL] [Abstract][Full Text] [Related]
9. Design and analysis of prostate cancer trials. Sylvester R Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926 [TBL] [Abstract][Full Text] [Related]
10. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. Dilts DM; Sandler AB J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693 [TBL] [Abstract][Full Text] [Related]
11. [From empiricism to therapeutic trials. Or how statistical methods can contribute to the improvement of therapeutic protocols in cervicofacial oncology]. Cachin Y; Flamant R; Richard J; Sancho-Garnier H Ann Otolaryngol Chir Cervicofac; 1982; 99(1-2):47-52. PubMed ID: 7103330 [No Abstract] [Full Text] [Related]
12. Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part I. Introduction. Schmale AH Cancer Treat Rep; 1980; 64(2-3):441-3. PubMed ID: 7407782 [TBL] [Abstract][Full Text] [Related]
13. Basics of methodologic analysis of therapeutic trials. Part I: Validity of the results. Soares I; Carneiro AV Rev Port Cardiol; 2002 Apr; 21(4):457-69. PubMed ID: 12090131 [TBL] [Abstract][Full Text] [Related]
14. [Statistical methods in the evaluation of the therapeutic efficacy--their problems and solutions]. Tominaga S Gan To Kagaku Ryoho; 1982 Nov; 9(11):1873-81. PubMed ID: 6764094 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy in invasive bladder cancer. Trial design and statistics. Dalesio O Prog Clin Biol Res; 1990; 353():57-64. PubMed ID: 2217427 [No Abstract] [Full Text] [Related]
16. A clinical development paradigm for cancer vaccines and related biologics. Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G; J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079 [TBL] [Abstract][Full Text] [Related]
17. A sequential procedure for monitoring clinical trials against historical controls. Xiong X; Tan M; Boyett J Stat Med; 2007 Mar; 26(7):1497-511. PubMed ID: 16900551 [TBL] [Abstract][Full Text] [Related]
18. Translating research into clinical practice: critical interpretation of clinical trials in schizophrenia. Leucht S Int Clin Psychopharmacol; 2006 Mar; 21 Suppl 2():S1-10. PubMed ID: 16601507 [TBL] [Abstract][Full Text] [Related]
19. Biostatistics in clinical trials: Part 2. Determining sample sizes for clinical trials. Ellenberg SS Oncology (Williston Park); 1989 Aug; 3(8):39-46; discussion 48, 51. PubMed ID: 2519197 [TBL] [Abstract][Full Text] [Related]
20. [Comparative clinical trials]. Yokoyama M Gan To Kagaku Ryoho; 1984 Mar; 11(3):404-12. PubMed ID: 6703720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]